Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia
Acute Myeloid Leukemia (AML) develops following multiple mutations of differing impact. Here, the authors show that activating mutations of CSF3R co-operate with loss-of-function mutations of CEBPA to promote AML development through an enhancer-dependent mechanism.
Main Authors: | Theodore P. Braun, Mariam Okhovat, Cody Coblentz, Sarah A. Carratt, Amy Foley, Zachary Schonrock, Brittany M. Smith, Kimberly Nevonen, Brett Davis, Brianna Garcia, Dorian LaTocha, Benjamin R. Weeder, Michal R. Grzadkowski, Joey C. Estabrook, Hannah G. Manning, Kevin Watanabe-Smith, Sophia Jeng, Jenny L. Smith, Amanda R. Leonti, Rhonda E. Ries, Shannon McWeeney, Cristina Di Genua, Roy Drissen, Claus Nerlov, Soheil Meshinchi, Lucia Carbone, Brian J. Druker, Julia E. Maxson |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2019-11-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-019-13364-2 |
Similar Items
-
Studies on CEBPA mutations in acute myeloid leukaemia
by: Green, C. L.
Published: (2012) -
Application of CEBPA Methylation in Acute Myeloid Leukemia
by: Tsung-Chin Lin, et al.
Published: (2011) -
Germline CEBPA mutation in familial acute myeloid leukemia
by: Matilde Boada, et al.
Published: (2021-10-01) -
Prognostic Nomogram for Acute Myeloid Leukemia Patients With Biallelic CEBPA Mutations
by: Xiaoyu Xu, et al.
Published: (2021-08-01) -
The regulatory control of Cebpa enhancers and silencers in the myeloid and red-blood cell lineages.
by: Andrea Repele, et al.
Published: (2019-01-01)